These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 34367253)
1. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer. Pan X; Bi F Front Genet; 2021; 12():694009. PubMed ID: 34367253 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
4. Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer. Wang J; Zhang X; Zheng F; Yang Q; Bi F J Ovarian Res; 2023 Aug; 16(1):177. PubMed ID: 37633972 [TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
6. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients. Peng J; Hao Y; Rao B; Zhang Z Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma. Liu N; Liu Z; Liu X; Chen H Front Oncol; 2019; 9():935. PubMed ID: 31649871 [TBL] [Abstract][Full Text] [Related]
8. Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer. Zheng J; Guo J; Zhang H; Cao B; Xu G; Zhang Z; Tong J Front Genet; 2021; 12():672674. PubMed ID: 34367239 [TBL] [Abstract][Full Text] [Related]
9. Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network. Liang H; Bai Y; Wang H; Yang X Front Genet; 2020; 11():566497. PubMed ID: 33664764 [TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma. Zhou S; Fang J; Sun Y; Li H Front Genet; 2020; 11():934. PubMed ID: 33193574 [TBL] [Abstract][Full Text] [Related]
12. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma. Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G Front Genet; 2022; 13():890641. PubMed ID: 35860468 [No Abstract] [Full Text] [Related]
13. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
14. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
15. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
16. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer. Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M Front Oncol; 2022; 12():780950. PubMed ID: 35280739 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
18. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer. Fan Q; Liu B Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer. Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758 [TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis. Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y Front Genet; 2022; 13():760514. PubMed ID: 35273635 [No Abstract] [Full Text] [Related] [Next] [New Search]